We are live on ! Find out more
Tudor Investment Corp

Tudor Investment Corp Portfolio holdings

AUM $53.9B
1-Year Est. Return 29.12%
This Fund
S&P 500
This Quarter Est. Return
-3.9%
1 Year Est. Return
+29.12%
3 Year Est. Return
+77.1%
5 Year Est. Return
+83.79%
10 Year Est. Return
+526.01%
AUM
$30.1B
AUM Growth
+$3.82B
Cap. Flow
+$6.13B
Cap. Flow %
20.35%
Top 10 Hldgs %
39.75%
Holding
3,818
New
874
Increased
1,161
Reduced
890
Closed
844

Sector Composition

Rank Sector Weight
1 Technology 5.92%
2 Financials 4.33%
3 Healthcare 3.85%
4 Consumer Discretionary 3.59%
5 Industrials 3.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CURB
1751
Curbline Properties
CURB
$3.46B
$1.11M ﹤0.01%
+45,991
New +$1.11M
VERA icon
1752
Vera Therapeutics
VERA
$2.08B
$1.11M ﹤0.01%
46,063
+14,220
+45% +$457K
DXCM icon
1753
PUT
DexCom
DXCM
$34.5B
$1.11M ﹤0.01%
16,200
+13,300
+459% +$1.09M
BFS
1754
Saul Centers
BFS
$865M
$1.1M ﹤0.01%
30,622
-6,819
-18% -$250K
IWP icon
1755
iShares Russell Mid-Cap Growth ETF
IWP
$21.1B
$1.1M ﹤0.01%
+9,343
New +$1.2M
GPN icon
1756
PUT
Global Payments
GPN
$25.1B
$1.1M ﹤0.01%
11,200
+7,500
+203% +$785K
NEO icon
1757
NeoGenomics
NEO
$2.11B
$1.09M ﹤0.01%
115,221
+27,868
+32% +$348K
THO icon
1758
Thor Industries
THO
$4.11B
$1.09M ﹤0.01%
14,409
+7,038
+95% +$662K
AVAH icon
1759
Aveanna Healthcare
AVAH
$2.46B
$1.09M ﹤0.01%
200,687
-14,291
-7% -$67.4K
DAR icon
1760
PUT
Darling Ingredients
DAR
$10.4B
$1.09M ﹤0.01%
34,800
+11,700
+51% +$409K
JAZZ icon
1761
Jazz Pharmaceuticals
JAZZ
$16B
$1.09M ﹤0.01%
+8,749
New +$1.14M
GLW icon
1762
CALL
Corning
GLW
$137B
$1.08M ﹤0.01%
23,700
-29,000
-55% -$1.43M
HII icon
1763
CALL
Huntington Ingalls Industries
HII
$12.8B
$1.08M ﹤0.01%
5,300
+1,800
+51% +$342K
PBH icon
1764
Prestige Consumer Healthcare
PBH
$2.43B
$1.08M ﹤0.01%
12,537
-4,299
-26% -$353K
LRN icon
1765
CALL
Stride
LRN
$3.48B
$1.08M ﹤0.01%
8,500
-6,300
-43% -$796K
AEHR icon
1766
Aehr Test Systems
AEHR
$4.02B
$1.07M ﹤0.01%
147,094
-35,262
-19% -$390K
JACK icon
1767
PUT
Jack in the Box
JACK
$358M
$1.07M ﹤0.01%
39,400
-18,200
-32% -$670K
TTEK icon
1768
Tetra Tech
TTEK
$9.33B
$1.07M ﹤0.01%
+36,573
New +$1.23M
SYF icon
1769
PUT
Synchrony
SYF
$26.1B
$1.07M ﹤0.01%
20,200
-1,000
-5% -$61.8K
IIPR icon
1770
CALL
Innovative Industrial Properties
IIPR
$1.67B
$1.07M ﹤0.01%
19,700
+3,300
+20% +$229K
OKE icon
1771
CALL
Oneok
OKE
$58.4B
$1.06M ﹤0.01%
10,700
-99,200
-90% -$9.85M
EIG icon
1772
Employers Holdings
EIG
$871M
$1.06M ﹤0.01%
20,964
-26,872
-56% -$1.33M
EXPE icon
1773
CALL
Expedia Group
EXPE
$39.4B
$1.06M ﹤0.01%
+6,300
New +$1.15M
FOXA icon
1774
CALL
Fox Class A
FOXA
$27.5B
$1.06M ﹤0.01%
+18,700
New +$989K
SXI icon
1775
Standex International
SXI
$3.97B
$1.06M ﹤0.01%
+6,552
New +$1.2M

Similar funds

Tudor Investment Corp's Q1 2025 Portfolio in Review

As of Q1 2025, Tudor Investment Corp held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Tudor Investment Corp deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.

By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.

  • Tudor Investment Corp's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
  • Tudor Investment Corp added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
  • Tudor Investment Corp's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
  • Tudor Investment Corp fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
  • Tudor Investment Corp's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
  • Tudor Investment Corp opened 874 new positions and closed 844 in Q1 2025.
  • Tudor Investment Corp's portfolio value rose 15% quarter-over-quarter to $30.1B.

Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.